“Abilify has changed my life in less than a week. My anxiety and depression are gone. For months I suffered from consistent panic attacks, depressive episodes, crying spells. I had to drop out of college. This in combination with cymbalta has literally improved everything in days. My sex drive is back, my relationship is wonderful, I am smiling, laughing and happy all the time. I don’t. ABILIFY MAINTENA 400 MG SUSPENSION,EXTENDED REL. INTRAMUSCULAR SYRINGE PA,QL(1 per 28 days) 18 abiraterone 500 mg tablet QL(60 per 30 days) 18 abiraterone acetate 250 mg tab QL(120 per 30 days) 18 ABOUTTIME PEN NEEDLE 30 GAUGE X 5/16 OTC ABOUTTIME PEN NEEDLE 31 GAUGE X 3/16 OTC ABOUTTIME PEN NEEDLE 31 GAUGE X 5/16 OTC ABOUTTIME PEN NEEDLE 32 GAUGE X 5/32 OTC acamprosate calc dr 333 mg tab. ABILIFY MAINTENA®(aripiprazole) extended release injectable suspension; JYNARQUE®(tolvaptan) tablets; REXULTI®(brexpiprazole) tablets; SAMSCA®(tolvaptan) tablets; Register now. COVID-19 UPDATE. During this extraordinary time, Otsuka Patient Assistance Foundation, Inc. (OPAF) continues to assist patients that have been prescribed an Otsuka medication. Our foundation is open during our. ABILIFY MAINTENA ER 400 MG SYRINGE : 4: Non-Preferred Drug: 40%: 40%: Q:1 /28Days: ABIRATERONE 500 MG TABLET [ZYTIGA] 5: Specialty Tier: 27%: N/A: P : Drug Name Tier Nbr. Tier Description 30-Day Preferred Pharm 90-Day Mail Order Drug Usage Mgmt; ABIRATERONE ACETATE 250 MG TABLET [ZYTIGA] 5: Specialty Tier : 27%: N/A: P : Acamprosate Calcium DR 333 MG tablets [Campral] 4: Non-Preferred Drug: 40. ABILIFY MAINTENA is only to be administered by intramuscular injection by a healthcare professional. The recommended starting and maintenance dose of ABILIFY MAINTENA is 400 mg monthly (no sooner than 26 days after the previous injection). For patients who have never taken aripiprazole, establish tolerability with oral aripiprazole prior to initiating treatment with ABILIFY MAINTENA. Due to. BRAND GENERIC BRAND Aripiprazole ; Abilify, Abilify Maintena, Aristada Olanzapine ; Zyprexa, Zyprexa Zydis Asenapine ; Saphris Paliperidone ; Invega, Invega Sustenna. ABILIFY MAINTENA (aripiprazole) poudre et solvant pour suspension injectable à libération prolongée est un médicament indiqué dans le traitement d'entretien de la schizophrénie chez les adultes stabilisés sous aripiprazole oral. Sa formulation galénique, en poudre et solvant pour suspension injectable à libération prolongée, permet une administration intramusculaire mensuelle. Download and print the application; Collect all required documentation from your patient; Fax the application and the documentation to OPAF at 1-844-727-6274; Please note: Faxed applications are processed within 5 business days. If this is a time-sensitive request, please submit an application online. If you are applying for assistance for ABILIFY MAINTENA®(aripiprazole) extended release.